Ligand Pharmaceuticals Inc (LGND) 69.51 $LGND Insider

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ligand Pharmaceuticals Inc (LGND) 69.51 $LGND

Insider Trading Alert - LGND, NSP And FSLR Traded By Insiders
at The Street - Wed Mar 04, 11:52AM CST
Stocks with insider trader activity include LGND, NSP and FSLR
FSLR: 60.61 (-1.05), NSP: 52.85 (-0.55), LGND: 69.51 (+0.55)

Nasdaq stocks posting largest percentage increases
AP - Tue Mar 03, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
DTSI: 32.74 (-0.89), OREX: 7.10 (-0.91), ANY: 7.00 (+0.45), FCSC: 5.82 (-0.12), STAA: 7.28 (+0.14), LGND: 69.51 (+0.55), NXPI: 98.48 (-0.19), VICR: 14.50 (-0.45), TSRI: 4.63 (-0.24), STRZB: 33.11 (-1.18), SMRT: 12.31 (-0.09), STRZA: 33.35 (-0.72), OMER: 26.14 (-0.21)

Ligand Pharmaceuticals Weakens The Bear Case
Trevor Lowenthal - at Seeking Alpha - Tue Mar 03, 10:17AM CST

LGND: 69.51 (+0.55), AMGN: 154.88 (-4.72), CELG: 118.03 (-2.68)

Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 15.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 8:25AM CST
Ligand Pharmaceuticals (LGND) was a big mover last session, with its shares rising over 15% on the day.
LGND: 69.51 (+0.55), AFFX: 11.81 (-0.38)

Ligand to Present at the 27th Annual Roth Conference on March 9th
Business Wire - Tue Mar 03, 7:30AM CST
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, Chief Executive Officer of Ligand will present at the 27th Annual Roth Conference on Monday, March 9, 2015 at 2:30 p.m. Pacific (5:30 p.m. Eastern Time). The conference takes place at The Ritz-Carlton in Laguna Niguel, California.
LGND: 69.51 (+0.55)

Ligand up on Kyprolis study
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 3:05PM CST

AMGN: 154.88 (-4.72), LGND: 69.51 (+0.55)

Discussing The Sale Of Amvona Fund's Stake In World Wrestling Entertainment, Corporate Governance And Other Issues
Amvona - Seeking Alpha - Fri Feb 27, 5:59AM CST
To listen to the full interview, click here: Benzinga - Rev. Emmanuel Lemelson CIO Lemelson Capital - PreMarket Prep. Show (February 20, 2015) On February 20, 2015, Rev. Father Emmanuel Lemelson, Founder and President of The Lantern...
KLIC: 16.11 (+0.05), GEOS: 17.17 (-0.93), WWE: 17.17 (+0.08), LGND: 69.51 (+0.55), AAPL: 126.60 (+0.19), BABA: 84.40 (-1.70)

My Top Biotechnology Stocks For 2015
Stan Stafford - at Seeking Alpha - Thu Feb 19, 8:49AM CST

MDVN: 126.55 (-0.53), CBPO: 82.88 (+1.08), BIIB: 417.63 (-7.98), INSY: 57.69 (+0.08), MYGN: 35.13 (+0.34), PCYC: 254.56 (+0.34), GILD: 101.81 (-1.61), UTHR: 160.65 (-0.71), ALXN: 181.65 (-4.14), LGND: 69.51 (+0.55), ACOR: 34.74 (-0.56), REGN: 422.13 (-6.82), PDLI: 6.70 (-0.40)

Ligand Pharmaceutical (LGND) Upgraded From Hold to Buy
at The Street - Wed Feb 11, 12:40PM CST
Ligand Pharmaceutical (LGND) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
LGND: 69.51 (+0.55)

Ligand Pharmaceuticals Had Strong 2014, Shares Barely Moved, Time To Act
Chris Katje - at Seeking Alpha - Tue Feb 10, 3:24PM CST

LGND: 69.51 (+0.55)

Ritter Pharmaceuticals elects Matthew W. Foehr to board
M2 - Tue Feb 10, 5:58AM CST
Pharmaceutical company Ritter Pharmaceuticals revealed on Monday the addition of Matthew W. Foehr to its board of directors to increase its directors to five.
LGND: 69.51 (+0.55)

Glaxo Submits Another Revolade Application in the EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 4:54PM CST
GlaxoSmithKline (GSK) announced that it has submitted another marketing application for Revolade in the EU.
AGN: 233.51 (-1.90), LGND: 69.51 (+0.55), GSK: 46.73 (-0.87)

Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Feb 09, 12:57PM CST

LGND: 69.51 (+0.55)

Ligand Pharmaceuticals (LGND) Posts In-Line Q4 Earnings - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 9:03AM CST
Ligand Pharmaceuticals (LGND) Posts In-Line Q4 Earnings
LGND: 69.51 (+0.55)

Ligand meets 4Q profit forecasts
Automated Insights - Mon Feb 09, 7:48AM CST
LA JOLLA, Calif. (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Monday reported fourth-quarter profit of $7.1 million.
LGND: 69.51 (+0.55)

Ligand Pharmaceuticals EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 7:34AM CST

LGND: 69.51 (+0.55)

Ligand Reports Fourth Quarter and Full Year 2014 Financial Results
Business Wire - Mon Feb 09, 7:31AM CST
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and 12 months ended December 31, 2014, and provided an operating forecast and program updates.
LGND: 69.51 (+0.55)

Ritter Pharmaceuticals Names Matthew W. Foehr to Its Board of Directors
Business Wire - Mon Feb 09, 6:00AM CST
Ritter Pharmaceuticals, Inc., a privately held pharmaceutical company focused on gastrointestinal disorders, announces the appointment of Matthew W. Foehr to the Company's Board of Directors. Mr. Foehr is President and Chief Operating Officer of Ligand Pharmaceuticals (NASDAQ: LGND) and his appointment expands Ritter's Board membership to five Directors.
LGND: 69.51 (+0.55)

Ligand seeks additional indication for ITP drug Revolade from European Medicines Agency
M2 - Mon Feb 09, 5:54AM CST
Biopharmaceutical company Ligand Pharmaceuticals (NasdaqGM:LGND) disclosed on Friday the submission of data to the European Medicines Agency (EMA) of a variation to the Marketing Authorization for eltrombopag (Revolade) seeking an additional indication for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).
LGND: 69.51 (+0.55), GSK: 46.73 (-0.87)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 7

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 3

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 6

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 5

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 4

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 2

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 6

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
End -->

Top 5 Most Recently Viewed Articles

Alphabet's Earnings Outlook: Can Cloud Revenue Fuel Growth?

Updated Category News Views 160

Examining Alphabet's Earnings and Future Growth In the investment arena, Alphabet (NASDAQ: GOOGL) is capturing the attention of buyers eager to see its stock break through the significant threshold of $200 per share. This shift is anticipated to be catalyzed by an upcoming earnings report, which many analysts predict could deliver promising results. As the tech behemoth...

Continue Reading
Viamedia Expands Advertising Reach with New Collaborations

Updated Category News Views 183

Viamedia Enhances Its Advertising Network Viamedia, the nation's prominent independent advertising representative for digital and linear services, has recently announced exciting new advertising partnerships. This development signifies a major stride for the company, expanding its operational reach considerably. With these new agreements, Viamedia now collaborates with a...

Continue Reading
WeightWatchers Reports Growth as Stock Soars on New Strategies

Updated Category News Views 238

WeightWatchers Reports Strong Earnings Growth WW International, Inc. (NASDAQ: WW) has recently reported a notable increase in stock value following the release of their latest financial reports. The company announced that in their recent earnings review, they achieved a revenue of $172.1 million, which, although it showed a decrease of 10.8% compared to the previous year,...

Continue Reading
Investor Alert: Class Action Filed Against Unicycive Therapeutics

Updated Category News Views 165

Class Action Filed Against Unicycive Therapeutics, Inc. In an important development for investors, a class action lawsuit has been filed against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) and certain of its officers. This lawsuit arises during a period when the company was actively working on the approval of its new drug, oxylanthanum carbonate (OLC), targeting the...

Continue Reading
NorthEast Community Bancorp Declares Special Cash Dividend Announcement

Updated Category News Views 104

NorthEast Community Bancorp's Special Cash Dividend Announcement NorthEast Community Bancorp, Inc. (NASDAQ: NECB) has announced an exciting development for its shareholders. Recently, the Board of Directors declared a special cash dividend of $0.20 per share on its outstanding common stock. This cash dividend reflects the company's dedication to enhancing shareholder...

Continue Reading